Exelixis reported $2.04B in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 564.84M 16.77M
Acceleron Pharma XLRN:US $ 763.03M 47.8M
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Akebia Therapeutics AKBA:US $ 174.63M 39.26M
Amgen AMGN:US $ 8247M 1087M
AstraZeneca AZN:LN 15676M 1246M
Bayer BAYN:GR € 30389M 4199M
Biomarin Pharmaceutical BMRN:US $ 4241.57M 79.56M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Bristol Myers Squibb BMY:US $ 36808M 797M
Cytokinetics CYTK:US $ 16.49M 51.36M
Dicerna Pharmaceuticals DRNA:US $ 111.07M 15.33M
Eisai 4523:JP Y 722552M 19369M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Esperion Therapeutics ESPR:US $ -304310000 34.92M
Exelixis EXEL:US $ 2043.08M 131.89M
Genmab GEN:DC DK 20252M 157M
Glaxosmithkline GSK:US $ 15377M 512M
Immunogen IMGN:US $ 68.46M 25.66M
IONIS PHARMACEUT IONS:US $ 582.67M 97.89M
Macrogenics MGNX:US $ 319.04M 31.49M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Moderna Inc MRNA:US 6.7B 2.87B
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Novartis NOVN:VX SF 54042M 3519M
Puma Biotechnology PBYI:US $ 29.47M 13.03M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
Takeda 4502:JP Y 5299774M 126737M
Ultragenyx Pharmaceutical RARE:US $ 972.17M 82.41M
Xencor XNCR:US $ 646.94M 63.33M
YTE INCY:US $ 2935.86M 208.02M